Medicine, diseases

Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency

Medicinal products for human use

Critical Medicines Act

Shortage of medicines - how to address an emerging problem

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”)

EU options for improving access to medicines

Non-communicable diseases

European Medicines Agency

Standards of quality and safety for substances of human origin intended for human application

Serious cross-border threats to health

European One Health action plan against antimicrobial resistance (AMR)

Foreign policy consequences of the COVID-19 outbreak

Trade related aspects and implications of COVID-19

European Centre for Disease Prevention and Control

The gender perspective in the Covid-19 crisis and post-crisis period

Ebola crisis: long-term lessons and how to strengthen health systems in developing countries to prevent future crises

White Paper on nutrition, overweight and obesity related health issues

Reducing health inequalities in the EU

Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance

The role of the EU's development cooperation and humanitarian assistance in addressing the consequences of the COVID-19 pandemic

Sexual and reproductive health and rights

Third programme for the Union's action in the field of health (2014-2020)

Report from the Commission to the Council on the basis of Member States' reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare associated infections

The impact of COVID-19 closures of educational, cultural, youth and sports activities on children and young people in the EU

Prevention of age-related diseases of women

European initiative on Alzheimer’s disease and other dementias

Microbial challenge - rising threats from antimicrobial resistance

Evaluation of the management of H1N1 influenza in 2009-2010 in the EU

Protection of public health from endocrine disrupters

Action against cancer: European partnership

Voluntary and unpaid donation of tissues and cells

EU Digital COVID Certificate - Union citizens

Resolution on vaccine hesitancy and the drop in vaccination rates in Europe

Capital Requirements Regulation: adjustments in response to the COVID-19 pandemic

Resolution on the EU’s response to HIV/AIDS, tuberculosis and hepatitis C

Serious cross-border threats to health

Resolution on use of cannabis for medicinal purposes

Medicinal products for human and veterinary use

Resolution on Lyme disease (Borreliosis)

Patient safety, prevention and control of healthcare associated infections

Rare diseases: European action

Fund for European Aid to the Most Deprived (FEAD) 2014-2020: specific measures for addressing the COVID-19 crisis

EU Digital COVID Certificate - third-country nationals